ResMed (NYSE:RMD) and Dynatronics (NASDAQ:DYNT) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations.

Analyst Ratings

This is a summary of current ratings for ResMed and Dynatronics, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ResMed 0 3 4 0 2.57
Dynatronics 0 0 3 0 3.00

ResMed presently has a consensus target price of $118.33, suggesting a potential downside of 21.42%. Dynatronics has a consensus target price of $3.50, suggesting a potential upside of 403.52%. Given Dynatronics’ stronger consensus rating and higher possible upside, analysts plainly believe Dynatronics is more favorable than ResMed.

Profitability

This table compares ResMed and Dynatronics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ResMed 15.52% 26.72% 13.45%
Dynatronics -1.84% -12.16% -2.84%

Earnings and Valuation

This table compares ResMed and Dynatronics’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ResMed $2.61 billion 8.31 $404.59 million $3.64 41.37
Dynatronics $62.56 million 0.10 -$920,000.00 ($0.21) -3.31

ResMed has higher revenue and earnings than Dynatronics. Dynatronics is trading at a lower price-to-earnings ratio than ResMed, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

66.5% of ResMed shares are owned by institutional investors. Comparatively, 11.7% of Dynatronics shares are owned by institutional investors. 1.2% of ResMed shares are owned by company insiders. Comparatively, 22.7% of Dynatronics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Risk & Volatility

ResMed has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, Dynatronics has a beta of 0.02, meaning that its stock price is 98% less volatile than the S&P 500.

Summary

ResMed beats Dynatronics on 11 of the 14 factors compared between the two stocks.

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides humidifiers, carry bags, and breathing circuits; data communications and control products, such as AirView Diagnostics, EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules; U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; and myAir, a patient engagement application that provides sleep data and a daily score based on their previous night's data, as well as offers business management software and services to medical equipment and home health providers. It markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 120 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

About Dynatronics

Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products. The company also provides electrotherapy, ultrasound, phototherapy, and thermal therapy modalities; motorized and stationary treatment tables and mat platforms; custom athletic training equipment; and strength and cardio training equipment. In addition, it distributes a range of products, such as exercise equipment, treatment tables, treadmills, walkers, compression therapy devices, stair climbers, parallel bars, laser light therapy equipment, shortwave diathermy, and radial pulse equipment. The company sells its products to licensed practitioners, such as orthopedists, physical therapists, chiropractors, and athletic trainers, professional sports teams and universities, sports medicine specialists, post-acute care facilities, hospitals and clinics, retail distributors and equipment manufacturer partners through direct and independent sales representatives and independent dealers. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Cottonwood Heights, Utah.

Receive News & Ratings for ResMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ResMed and related companies with MarketBeat.com's FREE daily email newsletter.